157 related articles for article (PubMed ID: 35240525)
1. Identification of prophylactic drugs for oxaliplatin-induced peripheral neuropathy using big data.
Zamami Y; Niimura T; Kawashiri T; Goda M; Naito Y; Fukushima K; Ushio S; Aizawa F; Hamano H; Okada N; Yagi K; Miyata K; Takechi K; Chuma M; Koyama T; Kobayashi D; Shimazoe T; Fujino H; Izawa-Ishizawa Y; Ishizawa K
Biomed Pharmacother; 2022 Apr; 148():112744. PubMed ID: 35240525
[TBL] [Abstract][Full Text] [Related]
2. Thrombomodulin alfa prevents oxaliplatin-induced neuropathic symptoms through activation of thrombin-activatable fibrinolysis inhibitor and protein C without affecting anti-tumor activity.
Minami T; Takeda M; Sata M; Kato H; Yano K; Sakai T; Tsujita R; Kawasaki K; Ito A
Eur J Pharmacol; 2020 Aug; 880():173196. PubMed ID: 32416186
[TBL] [Abstract][Full Text] [Related]
3. Goshajinkigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents.
Ushio S; Egashira N; Sada H; Kawashiri T; Shirahama M; Masuguchi K; Oishi R
Eur J Cancer; 2012 Jun; 48(9):1407-13. PubMed ID: 21907570
[TBL] [Abstract][Full Text] [Related]
4. Exenatide Facilitates Recovery from Oxaliplatin-Induced Peripheral Neuropathy in Rats.
Fujita S; Ushio S; Ozawa N; Masuguchi K; Kawashiri T; Oishi R; Egashira N
PLoS One; 2015; 10(11):e0141921. PubMed ID: 26536615
[TBL] [Abstract][Full Text] [Related]
5. Oral administration of Cystine and Theanine ameliorates oxaliplatin-induced chronic peripheral neuropathy in rodents.
Kawashiri T; Kobayashi D; Egashira N; Tsuchiya T; Shimazoe T
Sci Rep; 2020 Jul; 10(1):12665. PubMed ID: 32728157
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effect of alogliptin on oxaliplatin-induced peripheral neuropathy in vivo and in vitro.
Shigematsu N; Kawashiri T; Kobayashi D; Shimizu S; Mine K; Hiromoto S; Uchida M; Egashira N; Shimazoe T
Sci Rep; 2020 Apr; 10(1):6734. PubMed ID: 32317735
[TBL] [Abstract][Full Text] [Related]
7. Dimethyl Fumarate Attenuates Oxaliplatin-Induced Peripheral Neuropathy without Affecting the Anti-tumor Activity of Oxaliplatin in Rodents.
Miyagi A; Kawashiri T; Shimizu S; Shigematsu N; Kobayashi D; Shimazoe T
Biol Pharm Bull; 2019; 42(4):638-644. PubMed ID: 30930422
[TBL] [Abstract][Full Text] [Related]
8. Omeprazole Suppresses Oxaliplatin-Induced Peripheral Neuropathy in a Rodent Model and Clinical Database.
Mine K; Kawashiri T; Inoue M; Kobayashi D; Mori K; Hiromoto S; Kudamatsu H; Uchida M; Egashira N; Koyanagi S; Ohdo S; Shimazoe T
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012136
[TBL] [Abstract][Full Text] [Related]
9. Ergothioneine ameliorates oxaliplatin-induced peripheral neuropathy in rats.
Nishida K; Takeuchi K; Hosoda A; Sugano S; Morisaki E; Ohishi A; Nagasawa K
Life Sci; 2018 Aug; 207():516-524. PubMed ID: 29981320
[TBL] [Abstract][Full Text] [Related]
10. [Basic evidence for efficacy of Goshajinkigan on oxaliplatin-induced neuropathy].
Ushio S; Kawashiri T; Egashira N
Nihon Yakurigaku Zasshi; 2014 Mar; 143(3):126-30. PubMed ID: 24614635
[No Abstract] [Full Text] [Related]
11. Protective Effect of a Mitochondria-Targeted Peptide against the Development of Chemotherapy-Induced Peripheral Neuropathy in Mice.
Toyama S; Shimoyama N; Szeto HH; Schiller PW; Shimoyama M
ACS Chem Neurosci; 2018 Jul; 9(7):1566-1571. PubMed ID: 29660270
[TBL] [Abstract][Full Text] [Related]
12. Antioxidants Improve Oxaliplatin-Induced Peripheral Neuropathy in Tumor-Bearing Mice Model: Role of Spinal Cord Oxidative Stress and Inflammation.
Agnes JP; Santos VWD; das Neves RN; Gonçalves RM; Delgobo M; Girardi CS; Lückemeyer DD; Ferreira MA; Macedo-Júnior SJ; Lopes SC; Spiller F; Gelain DP; Moreira JCF; Prediger RD; Ferreira J; Zanotto-Filho A
J Pain; 2021 Aug; 22(8):996-1013. PubMed ID: 33774154
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Agents for Oxaliplatin-Induced Peripheral Neuropathy; Experimental and Clinical Evidence.
Kawashiri T; Mine K; Kobayashi D; Inoue M; Ushio S; Uchida M; Egashira N; Shimazoe T
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573316
[TBL] [Abstract][Full Text] [Related]
14. Rosmarinic Acid Mitigates Mitochondrial Dysfunction and Spinal Glial Activation in Oxaliplatin-induced Peripheral Neuropathy.
Areti A; Komirishetty P; Kalvala AK; Nellaiappan K; Kumar A
Mol Neurobiol; 2018 Sep; 55(9):7463-7475. PubMed ID: 29427084
[TBL] [Abstract][Full Text] [Related]
15. Discovery and Preclinical Evaluation of a Novel Inhibitor of FABP5, ART26.12, Effective in Oxaliplatin-Induced Peripheral Neuropathy.
Warren G; Osborn M; Tsantoulas C; David-Pereira A; Cohn D; Duffy P; Ruston L; Johnson C; Bradshaw H; Kaczocha M; Ojima I; Yates A; O'Sullivan SE
J Pain; 2024 Jul; 25(7):104470. PubMed ID: 38232863
[TBL] [Abstract][Full Text] [Related]
16. An effective therapeutic approach for oxaliplatin-induced peripheral neuropathy using a combination therapy with goshajinkigan and bushi.
Mizuno K; Shibata K; Komatsu R; Omiya Y; Kase Y; Koizumi S
Cancer Biol Ther; 2016 Nov; 17(11):1206-1212. PubMed ID: 27416484
[TBL] [Abstract][Full Text] [Related]
17. Analgesic Effects of Sokeikakketsuto on Chemotherapy-Induced Mechanical Allodynia and Cold Hyperalgesia in Rats.
Nakamura H; Kawashiri T; Kobayashi D; Uchida M; Egashira N; Shimazoe T
Biol Pharm Bull; 2021; 44(2):271-274. PubMed ID: 33518680
[TBL] [Abstract][Full Text] [Related]
18. Ibudilast suppresses oxaliplatin-induced mechanical allodynia and neurodegeneration in rats.
Egashira N; Goto Y; Takahashi R; Iba H; Yamamoto S; Watanabe T; Kubota K; Kawashiri T; Taniguchi C; Katsurabayashi S; Iwasaki K
J Pharmacol Sci; 2021 Sep; 147(1):114-117. PubMed ID: 34294361
[TBL] [Abstract][Full Text] [Related]
19. Preventive Effects of Renin-angiotensin System Inhibitors on Oxaliplatin-induced Peripheral Neuropathy: A Retrospective Observational Study.
Uchida M; Kawazoe H; Takatori S; Namba H; Uozumi R; Tanaka A; Kawasaki H; Araki H
Clin Ther; 2018 Jul; 40(7):1214-1222.e1. PubMed ID: 29983264
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of single doses of elcatonin and pregabalin on oxaliplatin-induced cold and mechanical allodynia in rats.
Aoki M; Kurauchi Y; Mori A; Nakahara T; Sakamoto K; Ishii K
Biol Pharm Bull; 2014; 37(2):322-6. PubMed ID: 24492729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
